天辰生物医药（苏州）有限公司上海分公司

LongBio Pharma, headquartered in Zhangjiang High-tech Park, Shanghai, is a leading Chinese biotechnology company dedicated to pioneering global development of innovative therapeutic biologics. With an impressive history of groundbreaking achievements, including the development of a blockbuster antibody, several long-acting therapeutic proteins, and antibodies at various stages of clinical trials, the company's innovation and entrepreneurship team has established a robust track record. Leveraging proprietary technologies such as long-acting fusion proteins, high-profile antibodies, superior mammalian cell culture processes, and more, LongBio is actively developing drug candidates aimed at addressing blood diseases, allergy disorders, cancer, and rare diseases.

Equipped with state-of-the-art instruments, facilities, and cutting-edge technology, LongBio is steadfastly committed to fulfilling unmet medical needs for global patients. The company's most advanced project is poised for imminent global clinical development, marking a significant milestone in its mission to revolutionize healthcare through innovative solutions. As the company enters a period of rapid growth, it seeks exceptional talent to join its ranks and contribute to the flourishing of Chinese biopharmaceuticals on the global stage.